NCT05859386

Brief Summary

Mindfulness-Based Cognitive Therapy (MBCT) combines meditation practices from Mindfulness-Based Stress Reduction (MBSR) with cognitive behavioral therapy to improve mental health. Although there is evidence that MBCT provides a variety of mental health benefits, it is particularly designed to prevent depression relapse, which occurs in 80% of people with a history of two episodes of depression. MBCT reduces depression relapse rates by 30%, on average after an eight-week course, and has lower relapse rates than continuing antidepressant medication. However, it is unknown what should be done following the program to optimize its long-term benefit. The investigators plan to conduct a pilot study in preparation for larger-scale clinical trial to determine the most effective maintenance approaches once MBCT has ended. The investigators gathered stakeholder input from MBCT graduates and MBCT teachers to inform the development of maintenance programs for MBCT. From this the investigators formulated several components of a maintenance program for MBCT. This includes providing a booster course for people who have already completed the MBCT program. This will be delivered as a 4-week course, meeting weekly, followed by monthly sessions to help participants build self-efficacy and agency with regard to creating their own plan for relapse prevention. This booster course is adapted from a 12-week program developed by Dr. Willem Kuyken at the Oxford Centre for Mindfulness. The team is planning the following sessions: 1 Deepening mindfulness with a focus on interoceptive awareness. 2) Hedonic system: Appreciating the light within. This would focus on positive emotion. 3) Responding not reacting 4) Two themes: taking care of ourselves, taking care of others. Integrating lessons into daily life with regards to sleep, diet, healthy relationships, behavioral activation. The study will also provide monthly follow-up sessions. The current study is a pilot study aimed at refining the intervention, providing initial data on acceptability and feasibility, and preliminary use of outcome measures in the context of the proposed study design.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at below P25 for not_applicable depression

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 3, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 4, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 16, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 19, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 19, 2024

Completed
Last Updated

July 3, 2024

Status Verified

July 1, 2024

Enrollment Period

11 months

First QC Date

May 4, 2023

Last Update Submit

July 2, 2024

Conditions

Keywords

depressionmindfulness

Outcome Measures

Primary Outcomes (1)

  • Client Satisfaction Scale (CSQ) scores

    Self-assessed satisfaction with care will be measured using the CSQ questionnaire. Scores on the 1979 version of the CSQ questionnaire range from 8 to 32, with higher scores indicating higher levels of satisfaction.

    4 months

Secondary Outcomes (5)

  • Client Satisfaction Scale (CSQ) scores

    1 month

  • Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Depression 8a scores

    Baseline to 4 months change

  • Change in Experiences Questionnaire scores

    Baseline to 4 months change

  • Change in Five Facet Mindfulness Questionnaire-short form (FFMQ-sf) scores

    Baseline to 4 months change

  • Change in Self-Compassion Scale-Short Form (SCS-sf) scores

    Baseline to 4 months change

Study Arms (2)

Mindfulness maintenance program

EXPERIMENTAL

Participants receive: (1) Four-week course to strengthen and extend skills learned in 8-week MBCT course, (2) Monthly 1.5 hour meeting session, and (3) Monthly check-in survey.

Behavioral: Mindfulness maintenance program

Wait-list

NO INTERVENTION

Participants receive follow-up measures but no intervention until the end of the wait-list period.

Interventions

1. Four-week course to strengthen and extend skills learned in 8-week MBCT course. This will consist of four 2-hour sessions, occurring weekly for four weeks. 2. Monthly 1.5 hour meeting sessions. These will be led by an experienced MBCT teacher and will consist of a group meditation practice, a check-in time, and discussion of a topic relevant to the MBSR course. 3. Monthly check-in survey. This will be a brief (5 - 10 minute) survey (using Qualtrics) with questions about mood (PROMIS Depression and Positive Affect scales) and recent meditation practice.

Mindfulness maintenance program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18+
  • Previously completed MBCT program.
  • A main reason (per self-report) for taking MBCT was for depression
  • \. Have smartphone or other device for attending virtual classes 6. Ability to speak and read English 7. Lives in US

You may not qualify if:

  • Patient Health Questionnaire 8 (PHQ8) score \>14 or 5+ items endorsed "more than half the days" or more, one of which corresponds to Question #1 or #2 (generally regarded as indicative of current Major Depressive Disorder).
  • High current risk of suicide on Columbia-Suicide Severity Rating Scale (CSSR-S) or history of attempt in past year
  • Unable or unwilling to attend Zoom group-based sessions as scheduled
  • History of Bipolar 1 disorder, Psychosis or Schizophrenia, or Borderline Personality disorder
  • Substance use, mental health, or other condition that in the opinion of the investigators will make participation in a group setting difficult.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSF

San Francisco, California, 94143-1726, United States

Location

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Frederick Hecht, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The first group will be a single group aimed at initial intervention refinement. The second group will be randomized to either receive the intervention or enter a wait-list control condition.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2023

First Posted

May 16, 2023

Study Start

April 3, 2023

Primary Completion

February 19, 2024

Study Completion

February 19, 2024

Last Updated

July 3, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations